COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Allogeneic ABCB5-positive Stem Cells for Treatment of CVU

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03257098
Recruitment Status : Recruiting
First Posted : August 22, 2017
Last Update Posted : February 19, 2020
FGK Clinical Research GmbH
Ticeba GmbH
Granzer Regulatory Consulting & Services
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 2021
Estimated Study Completion Date : June 2021